SABMiller non-exec invests £104,000
A round-up of the biggest director deals today so far.
John Manser, who has been a non-executive director of SABMiller for a decade has bought 5,000 shares in the brewer.
Manser paid 2083.82p a share for the 5,000 shares, which cost a total of £104,000. He has taken advantage of the weakness in the share price since the beginning of 2011.
Organic volumes of lager, which strip out the effects of acquisitions and disposals, rose 3% in the Peroni and Grolsch firm's third quarter. They're up 2% for the first nine months, helped by better economic conditions in many of its emerging markets.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Soft drinks volumes grew 5% on an organic basis and were up 3% for the first nine months.
Top Director Buys
SABMiller (SAB) Director name: Mr John ManserAmount purchased: 5,000 @ 2,083.82p Value: £104,191
Artemis Alpha Trust (ATS) Director name: Mr Ian R DigheAmount purchased: 6,325 @ 322.00p Value: £20,366
Polar Capital Holdings (POLR) Director name: Mr Hugh AldousAmount purchased: 10,000 @ 143.00p Value: £14,300
Nasstar (NASA) Director name: Mr Maurice Anthony EveAmount purchased: 71,724 @ 14.50p Value: £10,400
Top Director Sells
Imperial Innovations Group (IVO) Director name: Ms Susan SearleAmount sold: 24,012 @ 350.00p Value: £84,042
Imperial Innovations Group (IVO) Director name: Mr Julian SmithAmount sold: 18,860 @ 350.00p Value: £66,010
City of London Investment Group (CLIG) Director name: Mr Douglas F AllisonAmount sold: 10,000 @ 440.00p Value: £44,000
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Why now is the right time to invest in biotech
The biotech sector holds huge potential for investors, with strong growth and attractive valuations. Here's the best way to play it.
-
Zoopla: Busiest home buying May since 2021, but property asking prices slide
Buyers return to the market after the end of higher stamp duty thresholds and post-Easter lulls, but average sales are £16,000 below asking price